Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Gross Margin (2016 - 2026)

Apyx Medical filings provide 15 years of Gross Margin readings, the most recent being 62.61% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 42.0% to 62.61% in Q4 2025 year-over-year; TTM through Dec 2025 was 62.53%, a 149.0% increase, with the full-year FY2025 number at 62.53%, up 149.0% from a year prior.
  • Gross Margin hit 62.61% in Q4 2025 for Apyx Medical, down from 64.43% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 72.22% in Q4 2021 to a low of 58.07% in Q1 2024.
  • Median Gross Margin over the past 5 years was 63.8% (2022), compared with a mean of 64.39%.
  • Biggest five-year swings in Gross Margin: soared 1838bps in 2021 and later plummeted -688bps in 2022.
  • Apyx Medical's Gross Margin stood at 72.22% in 2021, then dropped by -10bps to 65.35% in 2022, then decreased by -7bps to 60.9% in 2023, then rose by 3bps to 63.03% in 2024, then decreased by -1bps to 62.61% in 2025.
  • The last three reported values for Gross Margin were 62.61% (Q4 2025), 64.43% (Q3 2025), and 62.28% (Q2 2025) per Business Quant data.